ARTICLE | Clinical News
Tecentriq atezolizumab regulatory update
October 24, 2016 7:00 AM UTC
FDA approved Tecentriq atezolizumab from Roche’s Genentech unit to treat metastatic non-small cell lung cancer (NSCLC). The human mAb against PD-L1 is indicated in patients whose disease has progresse...